The equity market is facing one of the best backdrops for sustained gains in years. After a prolonged period of elevated risks (global trade war, COVID-19 pandemic, US election uncertainty, etc.), the outlook is significantly clearing up, especially with news of a highly effective COVID-19 vaccine. We expected an imminent vaccine outcome and a rotation out of COVID-19 beneficiaries /…
Unfortunately our monthly-cycle, weekend macro-market Research Report will be postponed until Sunday October 30, 2022, due to an unexpected...
One could make the argument that this is one of the more predictable market pullbacks in recent memory. The...
In January, the “inventor” of the yield-curve indicator—Campbell Harvey of Duke University—suggested that the inversion of the 10Y/3M spread...
Cyclicals and small caps have gained more attention even as fiscal deal looks less likely because economic recovery has...
As we enter the corrective phase of the market moves, we seek the guidance of technical analysis to provide...
Through no fault of my own I’ve recently found myself at the heart of the mainstream, short- volatility (VOL),...
The S&P 500 Index is up to a record 53 new all-time highs by the end August, topping...
Welcome back! Every week, Seth and I discuss all the facets of the market and what are the factors...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
